BRD-A40787240-066-03-8
HELA
maintaining cell culture
L1000-Phase2
cervical adenocarcinoma
datapackage.zip
LINCS
L1000 LINCS DCIC REP.A013 HELA 24H H23 gemifloxacin 0.12um.tsv.gz
uterine cervix
Label
Description
A Substance
A 161 KB file from LINCS produced from OBI:0002965 as part of the L1000 Phase2 project